21st Century Oncology Appoints Chief Executive Officer – Kimberly Commins-Tzoumakas

NEXT STORY
Terveystalo Plc recognizes deferred tax assets with a positive, one-time net result impact of approximately EUR 13 million in the first quarter of 2018
PREV STORY
Basilea shareholders approve all proposals of the Board of Directors at the Annual General Meeting of Shareholders
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Intellipharmaceutics to Present at the Biotech Showcase™

TORONTO, Dec. 21, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I)("Intellipharmaceutics" or the ...

author_avatar
NASDAQ Market News

Oasmia tillsätter Business Advisory Board

author_avatar
NASDAQ Market News

Albireo to Host KOL Meeting on Rare Pediatric Liver Diseases on April 12

BOSTON, April 10, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan ...

author_avatar
NASDAQ Market News